Hepta Medical, a Paris-based medical device company focused on thermal ablation therapy for early-stage lung cancer, has successfully raised €5.7 million in a Series A financing round. This funding round was led by Bpifrance and included participation from M&L Healthcare and Clery IG. Founded in 2019 out of the medical device incubator MD Start, supported by Sofinnova Partners, Hepta Medical plans to use the capital to initiate the US regulatory approval process and to begin clinical trials. Goodwin’s Paris Life Sciences team, led by Xavier Leroux and supported by Julie Messerig, advised Hepta Medical on corporate aspects of the financing.
Healthcare, Medical Devices, Venture Capital,France, United States
https://www.goodwinlaw.com/en/news-and-events/news/2024/09/announcements-lifesciences-hepta-medical-series-a-financing